Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001921094-23-001004
Filing Date
2023-12-06
Accepted
2023-12-06 16:28:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 7166
  Complete submission text file 0001921094-23-001004.txt   8515
Mailing Address C/O ESPERION THERAPEUTICS, INC. 46701 COMMERCE CENTER DRIVE PLYMOUTH MI 48170
Business Address
Ignelzi Troy A. (Reporting) CIK: 0001579829 (see all company filings)

Type: 144

Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Subject) CIK: 0001771917 (see all company filings)

EIN.: 270605902 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38958 | Film No.: 231469929
SIC: 2834 Pharmaceutical Preparations